Rhythm Pharmaceuticals furnishes corporate slide deck; no material changes disclosed

RHYTHM PHARMACEUTICALS, INC.

Slide deck posted to investors section of company website on January 9, 2023.
Deck covers setmelanotide for rare MC4R pathway diseases; no new data or milestones.
Exhibit contains only title slide and forward-looking statements; no financial or pipeline updates.

item 7.01 item 9.01

RHYTHM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-002258

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.